A company with roots in developing tools for translational research has raised $15.3 million to execute the first step of its pursuit of market share in diagnostics. When it was granted the CE Mark in ...

Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...

In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: “10x Genomics (TXG), Inc. and Prognosys Biosciences, Inc. sued NanoString Technologies, Inc.1 ...

Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research Under the asset purchase agreement, Bruker has now acquired ...

* NANOSTRING TECHNOLOGIES-TO USE ABOUT $89.0 MILLION OF NET PROCEEDS TO PREPAY AMOUNTS BORROWED, FEES OWING RELATED TO TERMINATION OF SENIOR TERM LOAN FACILITY * NANOSTRING-TO USE ABOUT $89.0 MILLION ...

UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect Eric S. Whitaker, Chief Legal Officer for 10x Genomics, said, ...

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick ...

Rick: I’m back after a pause in the newsletter last week following my biking accident. Thanks for your patience, everyone. I also received multiple kind notes from readers regarding my dislocated ...

The results of a UK government consultation on the exhaustion of IP rights and an annual review published by the EPO’s Boards of Appeal were also among the top talking points this week We review ...

NanoString Technologies, the Seattle-based maker of genetic analysis instruments, has collected $2.5 million in new financing, according to a regulatory filing. NanoString's financing, which could be ...